Pituitary-adrenal responsiveness during prolonged administration of estrogen and 17-acetoxy-progesterone derived progestin.
D000324:Adrenocorticotropic Hormone; D000328:Adult; D002715:Chlormadinone Acetate / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000494:pharmacology; D008656:Mestranol / Q000494:pharmacology; D008797:Metyrapone; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011372:Progestins / Q000494:pharmacology*; D013997:Time Factors
D004967:Estrogens; D011372:Progestins; D002715:Chlormadinone Acetate; D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D008656:Mestranol; D008525:Medroxyprogesterone; D008797:Metyrapone